3 | SEC Filings Hub

Filing metadata

Accession number: 0001567619-23-007285
Form type: Form 3
Filer: 4D Molecular Therapeutics, Inc.
CIK: CIK 1650648
Filed: Sep 26, 2023
Reporting period: Sep 22, 2023
Description: Initial ownership

Documents

0001567619-23-007285-index.htm

Complete submission

0001567619-23-007285.txt

directory listing

Filed by

4D Molecular Therapeutics, Inc.